We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
+11.29%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.06B
AUM Growth
+$40.2M
(+3.9%)
Cap. Flow
-$31.9M
Cap. Flow
% of AUM
-3%
Top 10 Holdings %
Top 10 Hldgs %
38.82%
Holding
432
New
78
Increased
76
Reduced
169
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Diamondback Energy
FANG
|
+$61.4M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$26.6M |
| 3 |
Ovintiv
OVV
|
+$10M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$5.48M |
| 5 |
CHX
ChampionX
CHX
|
+$3.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DEN
Denbury Inc.
DEN
|
+$25.7M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$17.9M |
| 3 |
Antero Resources
AR
|
+$13.6M |
| 4 |
Accenture
ACN
|
+$10.7M |
| 5 |
Home Depot
HD
|
+$8.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 37.03% |
| 2 | Healthcare | 10.56% |
| 3 | Technology | 9.98% |
| 4 | Financials | 9.12% |
| 5 | Consumer Discretionary | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Xenon Pharmaceuticals
XENE
$6.32B
| $1.29M | 0.12% |
32,731
-3,707
| -10% | -$135K |
|
127
Privia Health
PRVA
$3.21B
| $1.25M | 0.12% |
54,933
-43,396
| -44% | -$1.21M |
|
128
Thryv Holdings
THRY
$169M
| $1.24M | 0.12% |
+65,055
| New | +$1.27M |
|
129
Oaktree Specialty Lending
OCSL
$1.03B
| $1.23M | 0.12% |
59,830
-3,715
| -6% | -$74.8K |
|
130
Immunocore
IMCR
$1.78B
| $1.22M | 0.11% |
21,401
-5,770
| -21% | -$325K |
|
|
DNB
131
DELISTED
Dun & Bradstreet
DNB
| $1.22M | 0.11% |
99,615
-4,160
| -4% | -$53.4K |
|
132
Portillo's
PTLO
$315M
| $1.22M | 0.11% |
74,771
-25,965
| -26% | -$520K |
|
133
Arcos Dorados Holdings
ARCO
$1.73B
| $1.2M | 0.11% |
143,657
+8,595
| +6% | +$64.3K |
|
134
American Express
AXP
$223B
| $1.19M | 0.11% |
8,062
| – | – |
|
135
Lam Research
LRCX
$382B
| $1.16M | 0.11% |
27,570
-30
| -0.1% | -$1.25K |
|
|
CBRG
136
DELISTED
Chain Bridge I Class A Ordinary Shares
CBRG
| $1.15M | 0.11% |
112,080
-57,130
| -34% | -$581K |
|
137
TechTarget
TTGT
$246M
| $1.15M | 0.11% |
26,135
-555
| -2% | -$29.1K |
|
138
Green Brick Partners
GRBK
$3.13B
| $1.15M | 0.11% |
+47,301
| New | +$1.09M |
|
139
Main Street Capital
MAIN
$4.97B
| $1.14M | 0.11% |
30,834
-731
| -2% | -$26.7K |
|
140
Fortune Brands Innovations
FBIN
$6.12B
| $1.14M | 0.11% |
19,933
-4,611
| -19% | -$242K |
|
141
Option Care Health
OPCH
$3.4B
| $1.14M | 0.11% |
37,812
-22,623
| -37% | -$702K |
|
142
WisdomTree True Developed International Fund
DOL
$813M
| $1.14M | 0.11% |
25,850
| – | – |
|
143
Thermo Fisher Scientific
TMO
$211B
| $1.13M | 0.11% |
2,048
-36
| -2% | -$19.1K |
|
144
Vanguard Mid-Cap ETF
VO
$106B
| $1.12M | 0.11% |
22,020
| – | – |
|
145
Hercules Capital
HTGC
$2.94B
| $1.12M | 0.11% |
84,799
-4,459
| -5% | -$60.6K |
|
146
STAAR Surgical
STAA
$1.16B
| $1.12M | 0.11% |
23,077
-39,905
| -63% | -$2.5M |
|
|
INTE
147
DELISTED
Integral Acquisition Corporation 1 Class A Common Stock
INTE
| $1.11M | 0.1% |
109,970
-5,970
| -5% | -$59.8K |
|
148
Sixth Street Specialty
TSLX
$1.59B
| $1.11M | 0.1% |
62,195
-7,068
| -10% | -$127K |
|
|
DCBO
149
Docebo
DCBO
$492M
| $1.11M | 0.1% |
+33,361
| New | +$1,000K |
|
|
VTYX
150
DELISTED
Ventyx Biosciences
VTYX
| $1.1M | 0.1% |
33,600
+1,874
| +6% | +$55.5K |
|
Similar funds
VFG
SLG
KCP
UAG
PS
CICI
RPAM
BBI
Advisory Research's Q4 2022 Portfolio in Review
As of Q4 2022, Advisory Research held 432 positions worth $1.06B, up 3.9% from $1.02B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Advisory Research withdrew a net $31.9M in Q4 2022, closing 68 positions and reducing 169 holdings. Its most notable exit was IAA, Inc. Common Stock, an estimated $6.06M position sold in full.
By sector, the portfolio is most concentrated in Energy at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Advisory Research opened a new position in iShares Russell 2000 ETF worth $5.37M.
- Advisory Research's largest Q4 2022 buy was iShares Russell 2000 ETF: 30,811 shares worth $5.37M.
- Advisory Research added most to Diamondback Energy in Q4 2022, an estimated $61.4M increase.
- Advisory Research's biggest Q4 2022 reduction was Denbury Inc., cutting an estimated $25.7M.
- Advisory Research fully exited IAA, Inc. Common Stock in Q4 2022, selling an estimated $6.06M.
- Advisory Research's ten largest holdings make up 39% of its $1.06B portfolio in Q4 2022.
- Advisory Research opened 78 new positions and closed 68 in Q4 2022.
- Advisory Research's portfolio value rose 3.9% quarter-over-quarter to $1.06B.
Based on Advisory Research's 13F filing for Q4 2022, filed 13 Feb 2023.